161 related articles for article (PubMed ID: 9084026)
1. Crystal size and properties of superparamagnetic iron oxide (SPIO) particles.
Sjögren CE; Johansson C; Naevestad A; Sontum PC; Briley-Saebø K; Fahlvik AK
Magn Reson Imaging; 1997; 15(1):55-67. PubMed ID: 9084026
[TBL] [Abstract][Full Text] [Related]
2. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.
Jung CW; Jacobs P
Magn Reson Imaging; 1995; 13(5):661-74. PubMed ID: 8569441
[TBL] [Abstract][Full Text] [Related]
3. [Transmission electron microscopy in the structural study of superparamagnetic contrast agents for MRI].
Lucet I; Filmon R; Pouliquen D; Le Jeune JJ; Jallet P
Bull Assoc Anat (Nancy); 1994 Mar; 78(240):57-9. PubMed ID: 7519906
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the magnetic properties of iron oxide nanoparticles used as contrast agent for MRI.
Pouliquen D; Perroud H; Calza F; Jallet P; Le Jeune JJ
Magn Reson Med; 1992 Mar; 24(1):75-84. PubMed ID: 1556931
[TBL] [Abstract][Full Text] [Related]
5. [Preparation and characterization of superparamagnetic iron oxide nanoparticles].
Liu ST; Yan Y; Chen ZL; Zhang YZ; Jin X
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):331-4. PubMed ID: 16546740
[TBL] [Abstract][Full Text] [Related]
6. Optimal design and characterization of superparamagnetic iron oxide nanoparticles coated with polyvinyl alcohol for targeted delivery and imaging.
Mahmoudi M; Simchi A; Imani M; Milani AS; Stroeve P
J Phys Chem B; 2008 Nov; 112(46):14470-81. PubMed ID: 18729404
[TBL] [Abstract][Full Text] [Related]
7. In situ analysis of a bimodal size distribution of superparamagnetic nanoparticles.
Thünemann AF; Rolf S; Knappe P; Weidner S
Anal Chem; 2009 Jan; 81(1):296-301. PubMed ID: 19117457
[TBL] [Abstract][Full Text] [Related]
8. A novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphography: comparison of physicochemical properties and the in vivo behaviour.
Lind K; Kresse M; Debus NP; Müller RH
J Drug Target; 2002 May; 10(3):221-30. PubMed ID: 12075823
[TBL] [Abstract][Full Text] [Related]
9. [A preparation technique for quantitative investigation of SPIO-containing solutions and SPIO-labelled cells by MRI].
Pintaske J; Helms G; Bantleon R; Kehlbach R; Wiskirchen J; Claussen CD; Schick F
Biomed Tech (Berl); 2005 Jun; 50(6):174-80. PubMed ID: 16003918
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-Conjugated Heparin-Coated Superparamagnetic Iron Oxide Nanoparticles for Combined Anticancer Drug Delivery and Magnetic Resonance Imaging.
Yang Y; Guo Q; Peng J; Su J; Lu X; Zhao Y; Qian Z
J Biomed Nanotechnol; 2016 Nov; 12(11):1963-74. PubMed ID: 29363935
[TBL] [Abstract][Full Text] [Related]
11. Preparation and quality test of superparamagnetic iron oxide labeled antisense oligodeoxynucleotide probe: a preliminary study.
Wen M; Li B; Ouyang Y; Luo Y; Li S
Ann Biomed Eng; 2009 Jun; 37(6):1240-50. PubMed ID: 19337837
[TBL] [Abstract][Full Text] [Related]
12. Magnetic characterization of iron oxides for magnetic resonance imaging.
Sjøgren CE; Briley-Saebø K; Hanson M; Johansson C
Magn Reson Med; 1994 Mar; 31(3):268-72. PubMed ID: 8057797
[TBL] [Abstract][Full Text] [Related]
13. The effects of iron oxides on proton relaxivity.
Josephson L; Lewis J; Jacobs P; Hahn PF; Stark DD
Magn Reson Imaging; 1988; 6(6):647-53. PubMed ID: 2850434
[TBL] [Abstract][Full Text] [Related]
14. Studying the effect of particle size and coating type on the blood kinetics of superparamagnetic iron oxide nanoparticles.
Roohi F; Lohrke J; Ide A; Schütz G; Dassler K
Int J Nanomedicine; 2012; 7():4447-58. PubMed ID: 22927759
[TBL] [Abstract][Full Text] [Related]
15. Ferrimagnetic susceptibility contrast agents.
Bach-Gansmo T
Acta Radiol Suppl; 1993; 387():1-30. PubMed ID: 8390776
[TBL] [Abstract][Full Text] [Related]
16. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.
Jung CW
Magn Reson Imaging; 1995; 13(5):675-91. PubMed ID: 8569442
[TBL] [Abstract][Full Text] [Related]
17. Superparamagnetic iron oxide for liver imaging. Comparison among three different preparations.
Bach-Gansmo T; Fahlvik AK; Ericsson A; Hemmingsson A
Invest Radiol; 1994 Mar; 29(3):339-44. PubMed ID: 8175309
[TBL] [Abstract][Full Text] [Related]
18. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison.
Sun R; Dittrich J; Le-Huu M; Mueller MM; Bedke J; Kartenbeck J; Lehmann WD; Krueger R; Bock M; Huss R; Seliger C; Gröne HJ; Misselwitz B; Semmler W; Kiessling F
Invest Radiol; 2005 Aug; 40(8):504-13. PubMed ID: 16024988
[TBL] [Abstract][Full Text] [Related]
19. The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles.
Huang DM; Hsiao JK; Chen YC; Chien LY; Yao M; Chen YK; Ko BS; Hsu SC; Tai LA; Cheng HY; Wang SW; Yang CS; Chen YC
Biomaterials; 2009 Aug; 30(22):3645-51. PubMed ID: 19359036
[TBL] [Abstract][Full Text] [Related]
20. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging.
Wang YX; Hussain SM; Krestin GP
Eur Radiol; 2001; 11(11):2319-31. PubMed ID: 11702180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
